Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Tobin

Showing results (101-110 of 142) with videos related to

Pageof 15
Sort By:
Glia|September 12, 2019
Astrocytes enhance glioblastoma growthAlessandro Mega, Mette Hartmark Nilsen, Lina Wik Leiss, et al.
Genome Research|November 3, 2001
High-throughput variation detection and genotyping using microarraysD J Cutler, M E Zwick, M M Carrasquillo, et al.
Therapeutic Advances in Medical Oncology|June 27, 2025
Pembrolizumab and all-trans retinoic acid combination treatment of advanced melanoma: long-term survival updateJessica S W Borgers, Theresa M Medina, William A Robinson, et al.
International Journal of Cancer|October 25, 2025
Progesterone receptor (PR) intra-tumor heterogeneity in premenopausal breast cancer: A secondary analysis of a randomized trialOscar Danielsson, Huma Dar, Gizeh Perez-Tenorio, et al.
International Journal of Cancer|February 18, 2022
Clinical and molecular characteristics of estrogen receptor-positive ultralow risk breast cancer tumors identified by the 70-gene signatureAnnelie Johansson, Nancy Y Yu, Adina Iftimi, et al.
Clinical Science (London, England : 1979)|June 24, 2017
Depletion of MHC class II invariant chain peptide or γ-δ T-cells ameliorates experimental preeclampsiaPiyali Chatterjee, Valorie L Chiasson, Geetha Seerangan, et al.
Cancers|May 14, 2022
BRAF Modulates Lipid Use and AccumulationJacqueline A Turner, Emily L Paton, Robert Van Gulick, et al.
JAMA Oncology|August 9, 2019
Assessment of Long-term Distant Recurrence-Free Survival Associated With Tamoxifen Therapy in Postmenopausal Patients With Luminal A or Luminal B Breast CancerNancy Y Yu, Adina Iftimi, Christina Yau, et al.
JAMA Oncology|June 30, 2017
Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk Over 2 DecadesLaura J Esserman, Christina Yau, Carlie K Thompson, et al.
Journal of the National Cancer Institute|December 10, 2024
Differential long-term tamoxifen therapy benefit by menopausal status in breast cancer patients: secondary analysis of a controlled randomized clinical trialAnnelie Johansson, Huma Dar, Anna Nordenskjöld, et al.
Pageof 15

Showing results (101-110 of 142) with videos related to

Sort By:
Pageof 15
Glia|September 12, 2019
Astrocytes enhance glioblastoma growthAlessandro Mega, Mette Hartmark Nilsen, Lina Wik Leiss, et al.
Genome Research|November 3, 2001
High-throughput variation detection and genotyping using microarraysD J Cutler, M E Zwick, M M Carrasquillo, et al.
Therapeutic Advances in Medical Oncology|June 27, 2025
Pembrolizumab and all-trans retinoic acid combination treatment of advanced melanoma: long-term survival updateJessica S W Borgers, Theresa M Medina, William A Robinson, et al.
International Journal of Cancer|October 25, 2025
Progesterone receptor (PR) intra-tumor heterogeneity in premenopausal breast cancer: A secondary analysis of a randomized trialOscar Danielsson, Huma Dar, Gizeh Perez-Tenorio, et al.
International Journal of Cancer|February 18, 2022
Clinical and molecular characteristics of estrogen receptor-positive ultralow risk breast cancer tumors identified by the 70-gene signatureAnnelie Johansson, Nancy Y Yu, Adina Iftimi, et al.
Clinical Science (London, England : 1979)|June 24, 2017
Depletion of MHC class II invariant chain peptide or γ-δ T-cells ameliorates experimental preeclampsiaPiyali Chatterjee, Valorie L Chiasson, Geetha Seerangan, et al.
Cancers|May 14, 2022
BRAF Modulates Lipid Use and AccumulationJacqueline A Turner, Emily L Paton, Robert Van Gulick, et al.
JAMA Oncology|August 9, 2019
Assessment of Long-term Distant Recurrence-Free Survival Associated With Tamoxifen Therapy in Postmenopausal Patients With Luminal A or Luminal B Breast CancerNancy Y Yu, Adina Iftimi, Christina Yau, et al.
JAMA Oncology|June 30, 2017
Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk Over 2 DecadesLaura J Esserman, Christina Yau, Carlie K Thompson, et al.
Journal of the National Cancer Institute|December 10, 2024
Differential long-term tamoxifen therapy benefit by menopausal status in breast cancer patients: secondary analysis of a controlled randomized clinical trialAnnelie Johansson, Huma Dar, Anna Nordenskjöld, et al.
Pageof 15